v3 Template
F

FibroGen, Inc.

Biopharmaceuticals / Healthcare San Francisco, USA ~105 employees
Founded
--
Employees (Est.)
~105
7 leaders known
Total Funding
$150.0M
Funding Rounds
1
Last Funding
2023-05-01

About FibroGen, Inc.

FibroGen is a biopharmaceutical company focused on accelerating the development of novel therapies at the frontiers of cancer biology. They are dedicated to innovation, helping patients worldwide with serious and life-threatening diseases through groundbreaking therapies.

Products & Services

Roxadustat:A product in development, likely for anemia treatment, as part of FibroGen's pipeline.
FG-3246:A product in development with associated clinical trials, potentially targeting specific diseases like cancer.

Specialties

Cancer Biology Prostate Cancer Anemia Chemotherapy-Induced Anemia Clinical Trials for Serious Diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Term Loan
T: -
FT: Term Loan 		A: 150000000
MR: -
FA: up to $150 million
FAN: 150000000 		D: 2023-05-01
FD: 2023-05-01 		1 investors
Term Loan Latest
2023-05-01
$150.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

James A. Schoeneck

Chairman of the Board

T

Thane Wettig

Chief Executive Officer

M

Maykin Ho, Ph.D.

Director

M

Michael G. Kauffman, MD, PhD

Director

J

Jeffrey L. Edwards

Director

D

David DeLucia

Chief Financial Officer

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

FibroGen, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals / Healthcare
Company Size
~105 employees (est.)
Locations
San Francisco, USA
San Francisco

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro